Oncology & Cancer

Immunotherapy for brain metastases: Where are we now?

Brain metastases are the most common type of brain tumors, affecting nearly 200,000 people in the United States each year. Once diagnosed, patients have a median survival of sic months. Immunotherapy, a type of cancer treatment ...

Medical research

Cancer cells soften as they metastasize, study suggests

When cancer cells metastasize, they often travel in the bloodstream to a remote tissue or organ, where they then escape by squeezing through the blood vessel wall and entering the site of metastasis. A study from MIT now ...

Oncology & Cancer

Why some melanoma patients do not respond to immunotherapy

By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients—across cancer types—do not respond, and in most cases, scientists are at ...

page 11 from 40